In this study, all patients connecting to the platform were invited to complete an anonymous online questionnaire including questions about demographics, chronic disease and treatment, and the 25-item ACCEPT questionnaire. The ACCEPT questionnaire includes 6 multi-item acceptance dimensions (Medication Inconvenience, Long-term Treatment, Regimen Constraints, Side Effects, Effectiveness and General), and one single-item acceptance dimension (Numerous Medications). Scores range from 0 to 100 for multi-item dimensions with higher score indicating greater acceptance. The single item dimension score is kept as the original 3-point response scale common to all items ("I don't find this easy to accept"; "I find this easy to accept"; "No" for patients not bothered by the subject addressed in the item).
Patients included in the present analysis were adult French patients, suffering from any chronic diseases and currently receiving a treatment for this disease. In addition, patients had to have completed at least one item of the ACCEPT questionnaire.
Descriptive statistics were used to describe the patient population and the ACCEPT scores. Pearson correlations between the Acceptance/General dimension and each of the other dimensions were calculated. Diseases with at least 30 patients were analysed individually, while other diseases were grouped together.
Analysis population (Figure 1 and Table 1)
Among the 4193 patients included in the analysis, more than 270 chronic diseases were represented, among which 19 including more than 30 patients.
Results

Methods
Objectives
Level of acceptance (Figure 2 and Table 2) None of the diseases was observed to have an extremely high mean acceptance score (mean Acceptance/General score <65 for all diseases).
For each disease, there were patients reporting the highest possible (100) and lowest possible (0) Acceptance/General score. This study is the first of its kind to collect data about patient acceptance toward their treatment in real life for a variety of chronic diseases with the ACCEPT questionnaire.
These data shall be of major interest to help evaluating and interpreting level of acceptance in future studies. They shall give clear indications of where are the current unmet needs and priorities of patients, for each of the studied diseases. Table 1 . Description of the patient population (N=4193) (Table 3) For all diseases, acceptance/General dimension was mostly correlated with Acceptance /Effectiveness dimension for all diseases.
Conclusions
For some diseases, Acceptance/General dimension was also strongly correlated with other dimension, in particular Acceptance/ Side effects. 
